Autor/in Baerlocher, G M 1 Gratwohl, A 1 Hehlmann, R 1 Hossfeld, D K 1 Kolb, H J 1 Krause, S 1 Lauseker, M 1 Nerl, C 1 Neubauer, A 1 Pfirrmann, M 1 Saußele, S alle zeigenListe einklappen
Assessment of imatinib as first-line treatment of chronic myeloid leukemia:10-year survival results of the randomized CML study IV and impact of non-CML determinants Hehlmann, R Lauseker, M Saußele, S Pfirrmann, M Krause, S Kolb, H J Neubauer, A 2017 - Forschungsinformationssystem des UKE
